Menu
GeneBe

rs59793293

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong

The NM_002055.5(GFAP):c.235C>T(p.Arg79Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000656 in 152,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R79L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)

Consequence

GFAP
NM_002055.5 missense

Scores

10
2
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4O:2

Conservation

PhyloP100: 8.00
Variant links:
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PM1
In a hotspot region, there are 9 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 12 uncertain in NM_002055.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr17-44915251-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 16170.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.991
PP5
Variant 17-44915252-G-A is Pathogenic according to our data. Variant chr17-44915252-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 16171.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GFAPNM_002055.5 linkuse as main transcriptc.235C>T p.Arg79Cys missense_variant 1/9 ENST00000588735.3
GFAPNM_001363846.2 linkuse as main transcriptc.235C>T p.Arg79Cys missense_variant 1/10
GFAPNM_001242376.3 linkuse as main transcriptc.235C>T p.Arg79Cys missense_variant 1/7
GFAPNM_001131019.3 linkuse as main transcriptc.235C>T p.Arg79Cys missense_variant 1/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GFAPENST00000588735.3 linkuse as main transcriptc.235C>T p.Arg79Cys missense_variant 1/91 NM_002055.5 P1P14136-1

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152250
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
Cov.:
31
GnomAD4 genome
AF:
0.00000656
AC:
1
AN:
152368
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74514
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2Other:1
not provided, no classification providedliterature onlyEpithelial Biology; Institute of Medical Biology, Singapore-- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxNov 19, 2021Published functional studies demonstrate that p.(R79C) significantly increases GFAP aggregation in zebra fish in comparison to wild-type (Lee et al., 2017) and impairs mitochondrial transfer from astrocytes to neighboring neurons (Gao et al., 2019); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 12509855, 23254569, 15696488, 18584981, 12034785, 12175861, 21533827, 11567214, 12581808, 15732097, 19128991, 18463287, 31484723, 33176815, 31327963, 11138011, 33084218, 34146839, 34692893, 17894839, 28882119) -
Pathogenic, criteria provided, single submitterclinical testingInvitaeAug 05, 2022This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg79 amino acid residue in GFAP. Other variant(s) that disrupt this residue have been observed in individuals with GFAP-related conditions (PMID: 11138011), which suggests that this may be a clinically significant amino acid residue. Experimental studies have shown that this missense change affects GFAP function (PMID: 28882119). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 16171). This missense change has been observed in individual(s) with Alexander disease (PMID: 11138011, 18584981, 23254569). In at least one individual the variant was observed to be de novo. This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 79 of the GFAP protein (p.Arg79Cys). -
Alexander disease Pathogenic:2Other:1
Pathogenic, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJul 25, 2022The GFAP c.235C>T p.(Arg79Cys) missense variant has been reported in a heterozygous state in at least seven individuals with Alexander disease, including five in whom it occurred in a de novo state (PMID: 11138011; PMID: 15696488; PMID: 18584981; PMID: 23254569; PMID: 31484723; PMID: 33176815). The c.235C>T variant is reported in the Genome Aggregation Database in one allele at a frequency of 0.000015 in the European (non-Finnish) population (version 3.1.2). Compared to wild-type GFAP, the p.(Arg79Cys) variant has been shown to significantly increase GFAP aggregation when expressed in zebrafish (PMID: 28882119). Mass spectroscopy studies in a patient with the variant suggested that levels of variant GFAP were lower than those of wild-type, suggesting an intrinsic toxicity of the variant form (PMID: 31484723). When expressed in human pluripotent stem cells induced to differentiate into astrocytes, the variant also impaired mitochondrial transfer from astrocytes and reduced astrocytic CD38 expression (PMID: 31327963). This variant was identified in a de novo state in the proband. Based on the available evidence, the c.235C>T (p.Arg79Cys) variant is classified as pathogenic for Alexander disease. -
Pathogenic, no assertion criteria providedliterature onlyOMIMNov 01, 2007- -
not provided, no classification providedliterature onlyGeneReviews-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.91
BayesDel_addAF
Pathogenic
0.53
D
BayesDel_noAF
Pathogenic
0.52
Cadd
Pathogenic
33
Dann
Pathogenic
1.0
Eigen
Uncertain
0.64
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.56
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Pathogenic
0.88
D
Polyphen
0.47
.;P;.;.;.;.;.;.;.
Vest4
0.99, 0.99
MutPred
0.98
Loss of MoRF binding (P = 0.0103);Loss of MoRF binding (P = 0.0103);Loss of MoRF binding (P = 0.0103);Loss of MoRF binding (P = 0.0103);Loss of MoRF binding (P = 0.0103);Loss of MoRF binding (P = 0.0103);Loss of MoRF binding (P = 0.0103);Loss of MoRF binding (P = 0.0103);Loss of MoRF binding (P = 0.0103);
MVP
1.0
MPC
1.4
ClinPred
1.0
D
GERP RS
3.9
Varity_R
0.90
gMVP
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs59793293; hg19: chr17-42992620; COSMIC: COSV99493595; COSMIC: COSV99493595; API